The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.

Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Global Marine Pharmaceuticals key players include Seattle Genetics, Inc., DSM, Eisai Co, Takeda, BASF, Amway, etc. Global top six manufacturers hold a share about 10%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share over 35 percent.
In terms of product, Health Supplement is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmacy, followed by Hospital & Clinic.

Market Analysis and Insights: Global and Japan Marine Pharmaceuticals Market
This report focuses on global and Japan Marine Pharmaceuticals market.
In 2020, the global Marine Pharmaceuticals market size was US$ 26500 million and it is expected to reach US$ 48130 million by the end of 2027, with a CAGR of 8.5% during 2021-2027. In Japan the Marine Pharmaceuticals market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Marine Pharmaceuticals Scope and Market Size
Marine Pharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Marine Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Marine Pharmaceuticals market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Drugs
Health Supplement

Segment by Application
Hospital & Clinic
Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs